Distribution of CYP2C19*17 allele and genotypes in an Indian population

Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

(2010) Dirk Sibbing et al.   CIRCULATION

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

(2009) Alain Li-Wan-Po et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients

(2009) P W Schenk et al.   PHARMACOGENOMICS JOURNAL

Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

(2008) Katsuyoshi Sugimoto et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians

(2008) Nicole G. Hunfeld et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

(2008) R. Michael Baldwin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Genetic polymorphism analysis ofCYP2C19in Chinese Han populations from different geographic areas of mainland China

(2008) Lingling Chen et al.   PHARMACOGENOMICS

Need for reassessment of reportedCYP2C19allele frequencies in various populations in view ofCYP2C19*17discovery: the case of Greece

(2008) Georgia Ragia et al.   PHARMACOGENOMICS